Capricor Therapeutics Inc (CAPR): EQNX::TICKER_START (NASDAQ:CAPR), EQNX::...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	494
Posts	32009
Boards Moderated	0
Alias Born	03/12/2014

Volcano

Re: None

Wednesday, 09/07/2022 10:48:05 AM

Wednesday, September 07, 2022 10:48:05 AM

EQNX::TICKER_START (NASDAQ:CAPR), EQNX::TICKER_END Capricor Therapeutics (NASDAQ: CAPR) a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases, announced today that the Company will present at the following upcoming investor conferences in September.

Conference and presentation details are as follows:

H.C. Wainwright 24 Annual Global Investment Conference (September 12 - 14, 2022)

Format: Presentation and one-on-one investor meetings

Date and Time: Sept. 13, 2022 from 1:30 - 2:00 p.m. ET

Webcast: Link

Cantor Fitzgerald Cell & Genetics Medicines Conference (September 15, 2022)

Format: Panel and one-on-one investor meetings

Title: Late-Stage and Commercial Gene & Cell Therapy Warriors: How They Got to/Crossed the Finish Line

Date and Time: Sept. 15, 2022 from 10:40 - 11:50 a.m. ET